212 related articles for article (PubMed ID: 21998580)
1. The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization.
Wuest T; Zheng M; Efstathiou S; Halford WP; Carr DJ
PLoS Pathog; 2011 Oct; 7(10):e1002278. PubMed ID: 21998580
[TBL] [Abstract][Full Text] [Related]
2. HSV-1 infection and pathogenesis in the tree shrew eye following corneal inoculation.
Li L; Li Y; Li X; Xia Y; Wang E; Gong D; Chen G; Yang L; Zhang K; Zhao Z; Fraser NW; Fan Q; Li B; Zhang H; Cao X; Zhou J
J Neurovirol; 2020 Jun; 26(3):391-403. PubMed ID: 32301037
[TBL] [Abstract][Full Text] [Related]
3. Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus.
Mulik S; Xu J; Reddy PB; Rajasagi NK; Gimenez F; Sharma S; Lu PY; Rouse BT
Am J Pathol; 2012 Aug; 181(2):525-34. PubMed ID: 22659469
[TBL] [Abstract][Full Text] [Related]
4. METTL3-mediated m
Wang W; Ye W; Chen S; Tang Y; Chen D; Lu Y; Wu Z; Huang Z; Ge Y
Cell Signal; 2023 Sep; 109():110784. PubMed ID: 37356601
[TBL] [Abstract][Full Text] [Related]
5. Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1.
Bhattacharjee PS; Neumann DM; Foster TP; Bouhanik S; Clement C; Vinay D; Thompson HW; Hill JM
Exp Eye Res; 2008 Aug; 87(2):122-30. PubMed ID: 18572164
[TBL] [Abstract][Full Text] [Related]
6. The herpes simplex virus type 1 ICP0 promoter is activated by viral reactivation stimuli in trigeminal ganglia neurons of transgenic mice.
Loiacono CM; Taus NS; Mitchell WJ
J Neurovirol; 2003 Jun; 9(3):336-45. PubMed ID: 12775417
[TBL] [Abstract][Full Text] [Related]
7. PEDF Reduces the Severity of Herpetic Simplex Keratitis in Mice.
Tian X; Wang T; Zhang S; Wang Q; Hu X; Ge C; Xie L; Zhou Q
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2923-2931. PubMed ID: 30025136
[TBL] [Abstract][Full Text] [Related]
8. A virus with a mutation in the ICP4-binding site in the L/ST promoter of herpes simplex virus type 1, but not a virus with a mutation in open reading frame P, exhibits cell-type-specific expression of gamma(1)34.5 transcripts and latency-associated transcripts.
Lee LY; Schaffer PA
J Virol; 1998 May; 72(5):4250-64. PubMed ID: 9557715
[TBL] [Abstract][Full Text] [Related]
9. Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4.
Gu B; DeLuca N
J Virol; 1994 Dec; 68(12):7953-65. PubMed ID: 7966586
[TBL] [Abstract][Full Text] [Related]
10. Identification of a promoter-specific transactivation domain in the herpes simplex virus regulatory protein ICP4.
Xiao W; Pizer LI; Wilcox KW
J Virol; 1997 Mar; 71(3):1757-65. PubMed ID: 9032304
[TBL] [Abstract][Full Text] [Related]
11. The Herpes Simplex Virus 1 Protein ICP4 Acts as both an Activator and a Repressor of Host Genome Transcription during Infection.
Rivas T; Goodrich JA; Kugel JF
Mol Cell Biol; 2021 Sep; 41(10):e0017121. PubMed ID: 34251885
[TBL] [Abstract][Full Text] [Related]
12. Herpes Simplex Virus 1 ICP22 Suppresses CD80 Expression by Murine Dendritic Cells.
Matundan H; Ghiasi H
J Virol; 2019 Feb; 93(3):. PubMed ID: 30404803
[TBL] [Abstract][Full Text] [Related]
13. Differential cellular requirements for activation of herpes simplex virus type 1 early (tk) and late (gC) promoters by ICP4.
Zabierowski S; DeLuca NA
J Virol; 2004 Jun; 78(12):6162-70. PubMed ID: 15163709
[TBL] [Abstract][Full Text] [Related]
14. Robo 4 Counteracts Angiogenesis in Herpetic Stromal Keratitis.
Gimenez F; Mulik S; Veiga-Parga T; Bhela S; Rouse BT
PLoS One; 2015; 10(12):e0141925. PubMed ID: 26720197
[TBL] [Abstract][Full Text] [Related]
15. Mapping Murine Corneal Neovascularization and Weight Loss Virulence Determinants in the Herpes Simplex Virus 1 Genome and the Detection of an Epistatic Interaction between the UL and IRS/US Regions.
Lee K; Kolb AW; Larsen I; Craven M; Brandt CR
J Virol; 2016 Sep; 90(18):8115-31. PubMed ID: 27384650
[TBL] [Abstract][Full Text] [Related]
16. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
17. The transgenic ICP4 promoter is activated in Schwann cells in trigeminal ganglia of mice latently infected with herpes simplex virus type 1.
Taus NS; Mitchell WJ
J Virol; 2001 Nov; 75(21):10401-8. PubMed ID: 11581408
[TBL] [Abstract][Full Text] [Related]
18. Suppression of transcription factor early growth response 1 reduces herpes simplex virus 1-induced corneal disease in mice.
Yao HW; Chen SH; Li C; Tung YY; Chen SH
J Virol; 2012 Aug; 86(16):8559-67. PubMed ID: 22647700
[TBL] [Abstract][Full Text] [Related]
19. The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1.
Lowry PW; Koropchak CM; Choi CY; Mocarski ES; Kern ER; Kinchington PR; Arvin AM
Antiviral Res; 1997 Feb; 33(3):187-200. PubMed ID: 9037375
[TBL] [Abstract][Full Text] [Related]
20. Equine herpesvirus 1 gene 12 can substitute for vmw65 in the growth of herpes simplex virus (HSV) type 1, allowing the generation of optimized cell lines for the propagation of HSV vectors with multiple immediate-early gene defects.
Thomas SK; Lilley CE; Latchman DS; Coffin RS
J Virol; 1999 Sep; 73(9):7399-409. PubMed ID: 10438830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
